Discover
CSBR
Champions Oncology, Inc.
5.26
2 x 3.47
2 x 6.52
bid
ask
-
0.04
0.75%
2 @ 04:55 PM
5.26 +0.00 (0.00%)
| Ytd | -23.88% | |
| 1y | -19.94% |
5.08
day range
5.30
4.59
52 week range
8.31
| Open | 5.30 | Prev Close | 5.30 | Low | 5.08 | High | 5.30 | Mkt Cap | 73.21M |
| Vol | 10.39K | Avg Vol | 10.64K | EPS | -0.08 | P/E | N/A | Forward P/E | 42.68 |
| Beta | 0.49 | Short Ratio | 20.86 | Inst. Own | 49.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-10 | 50-d Avg | 5.32 | 200-d Avg | 6.02 | 1yr Est | 8.00 |
| Income Statement | |||
| Total Revenue | 15.23M | ||
| Revenues (USD) | 15.23M | ||
| Cost of Revenue | 7.53M | ||
| Gross Profit | 7.70M | ||
| Operating Expenses | 8.11M | ||
| Research and Development Expense | 2.34M | ||
| Selling, General and Administrative Expense | 5.76M | ||
| Operating Income | -409.00K | ||
| Income Tax Expense | 11.00K | ||
| Net Income | -426.00K | ||
| Net Income Common Stock | -426.00K | ||
| Net Income Common Stock (USD) | -426.00K | ||
| Consolidated Income | -426.00K | ||
| Earnings per Basic Share | -0.03 | ||
| Earnings per Basic Share (USD) | -0.03 | ||
| Earning Before Interest & Taxes (EBIT) | -415.00K | ||
| Earning Before Interest & Taxes (USD) | -415.00K | ||
| Weighted Average Shares | 13.90M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.36M | ||
| Cash and Equivalents (USD) | 4.36M | ||
| Trade and Non-Trade Receivables | 13.60M | ||
| Current Assets | 19.29M | ||
| Property, Plant & Equipment Net | 13.46M | ||
| Total Assets | 33.29M | ||
| Debt Current | 635.00K | ||
| Total Debt | 10.52M | ||
| Current Liabilities | 18.73M | ||
| Debt Non-Current | 9.89M | ||
| Total Liabilities | 28.83M | ||
| Accumulated Retained Earnings (Deficit) | -81.49M | ||
| Shareholders Equity | 3.89M | ||
| Shareholders Equity (USD) | 3.89M | ||
| Assets Non-Current | 14.00M | ||
| Total Debt (USD) | 10.52M | ||
| Deferred Revenue | 9.55M | ||
| Goodwill and Intangible Assets | 335.00K | ||
| Liabilities Non-Current | 10.10M | ||
| Trade and Non-Trade Payables | 5.63M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 314.00K | ||
| Net Cash Flow from Financing | 33.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -514.00K | ||
| Capital Expenditure | -55.00K | ||
| Issuance (Purchase) of Equity Shares | 52.00K | ||
| Issuance (Repayment) of Debt Securities | -19.00K | ||
| Net Cash Flow from Investing | -55.00K | ||
| Net Cash Flow from Operations | -492.00K | ||
| Share Based Compensation | 766.00K | ||